A similar study showed that metformin can attenuate LPS-stimulated acute lung injury (ALI) capillary damage by activating AMPKα1, including reducing inflammatory cytokine release, neutrophil and macrophage infiltration, and reducing myeloperoxidase activity (56). The gene discussed is PRKAA1; the disease is acute respiratory distress syndrome.